WASHINGTON (dpa-AFX) - Avanir Pharmaceuticals, Inc. (AVNR) posted fourth-quarter net loss of $18.0 million or $0.14 per share, wider than $9.7 million or $0.10 per share in the previous year quarter.
Total revenues for the quarter was $4.8 million, up from $726 thousand in the previous year quarter.
On average, five analysts polled by Thomson Reuters expected the company to report a loss of $0.14 per share on revenues of $4.49 million for the quarter.
Copyright RTT News/dpa-AFX
© 2011 AFX News
